Article July 1, 2021

The EcoCyc Database in 2021

Article April 1, 2021

The BioCyc Metabolic Network Explorer

March 1, 2021

Pathway Size Matters: The Influence of Pathway Granularity on Over-Representation (Enrichment) Statistics

In the news June 17, 2020

BIO Digital International Convention 2020

SRI leaders highlighted SRI's novel platforms that are solving drug discovery & development challenges.

...Strategy Officer Nathan Collins and Director of Discovery Peter Madrid provide brief overviews of SRI’s groundbreaking platforms and approaches. Watch the presentation below: Or click here to access the presentation...

In the news June 13, 2020

How COVID-19 will accelerate Industry 4.0 & real-time intelligence

Peter Marcotullio, VP Business Dev. talks with Automation Alley in their latest COVID webinar.

Article May 3, 2020

Sleep Disturbance Predicts Depression Symptoms in Early Adolescence: Initial Findings From the Adolescent Brain Cognitive Development Study

Press release May 3, 2020

SRI International & SparkLabs Foundry Announce Strategic Global Partnership

...forefront of global innovation for more than 70 years,” said Peter Marcotullio, VP Global Partnerships at SRI International. “And yet, even with the many hundreds of government and commercial projects...

Announcements May 3, 2020

SRI Introduces Novel Synthetic Chemistry System at SLAS 2020

...p.m. Pacific Location: San Diego Convention Center, Room 6F   The same day, Peter Madrid, Ph.D., will provide a detailed overview of a recent SynFini application.   Session Title: Poster...

January 9, 2020

A Comparison of the Pathway Tools Software with the Reactome Software

Story November 8, 2019

A brief introduction to quantum computing

...rather by a quantum machine. In 1994 Peter Shor, a researcher at AT&T’s Bell Labs discovered a quantum algorithm that enabled quantum computers to factor large numbers much faster than...

October 5, 2019

The MetaCyc Database of Metabolic Pathways and Enzymes – A 2019 Update


Techneins™ – Non-natural polymers as synthetic affinity reagents and novel therapeutics

close check icon

Message Sent

Success! - Thank you for your interest.

share dwonload plus email external external project copy play call directions linkedin